Neurogan
US$ 25.66
dsip proposal number is Now LIVE - Accepting Phase II Proposals Innovation Small Business > Defense
Description
58 Co urine excretion of less than 10% (normal 1040%) was considered pathological [10]
Enhanced inhibition of syngeneic murine tumors by combinatorial therapy with genetically engineered HSV-1 expressing CCL2 and IL-12
Thicker needles (29 gauge) draw and inject faster but may cause slightly more discomfort at the injection site
doi:10.3109/10715762.2011.597750 Ambrogini P, Minelli A, Galati C, et al